MedPath

Theracal Pulpotomy in Primary Molars

Phase 4
Completed
Conditions
Deep Caries
Interventions
Drug: Formocresol
Drug: Theracal LC
Registration Number
NCT04397094
Lead Sponsor
Ain Shams University
Brief Summary

Light cured silicate based cement (theracal LC) pulpotomy was compared to formocresol pulpotomy in primary molars.

Detailed Description

sixty primary molars were either treated with Theracal LC or formocresol pulpotomy. Teeth were followed up clinicaly and radiographically for 12 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • healthy, cooperative children
  • mandibular primary molars with vital pulp exposures
Read More
Exclusion Criteria
  • clinical or radiographic evidence of irreversible pulpitis
  • physiological root resorption
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FormocresolFormocresolFormocresol was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months.
Theracal LCTheracal LCTheracal LC was used as a medicament to cover root stumps of asymptomatic thirty primary molars with vital pulp exposures. Teeth were followed up clinically and radiographically for 12 months.
Primary Outcome Measures
NameTimeMethod
Clinical Examination12 months

Number of participants with tooth mobility, restoration loss, gingival swelling/fistula, pain on percussion.

Secondary Outcome Measures
NameTimeMethod
Radiographic Examination12 months

Number of participants showing teeth with inter-radicular bone resorption, periapical bone resorption, internal root resorption, external root resorption, widening of periodontal ligament space.

Trial Locations

Locations (1)

Faculty of Dentistry, Ain Shams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath